Santarelli et al., 2011 - Google Patents
Presynaptic and postsynaptic mechanisms underlying auditory neuropathy in patients with mutations in the OTOF or OPA1 geneSantarelli et al., 2011
View PDF- Document ID
- 1847518377045869049
- Author
- Santarelli R
- Starr A
- Del Castillo I
- Huang T
- Scimemi P
- Cama E
- Rossi R
- Arslan E
- Publication year
- Publication venue
- Audiological Medicine
External Links
Snippet
Objective: Our objective was to compare acoustically-and electrically-evoked potentials of the auditory nerve in patients with postsynaptic or presynaptic auditory neuropathy with underlying mutations in the OPA1 or OTOF gene. Study design: Transtympanic …
- 230000035772 mutation 0 title abstract description 83
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/36032—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers of the outer, middle or inner ear, e.g. cochlear implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0476—Electroencephalography
- A61B5/0484—Electroencephalography using evoked response
- A61B5/04845—Electroencephalography using evoked response acoustically or auditory
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0541—Cochlear electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/12—Audiometering Evaluation or the auditory system, not limited to hearing capacity
- A61B5/121—Audiometering Evaluation or the auditory system, not limited to hearing capacity evaluating hearing capacity
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Allman et al. | Adult deafness induces somatosensory conversion of ferret auditory cortex | |
Sampaio et al. | New criteria of indication and selection of patients to cochlear implant | |
Shallop et al. | Cochlear implants in five cases of auditory neuropathy: postoperative findings and progress | |
McMahon et al. | Frequency-specific electrocochleography indicates that presynaptic and postsynaptic mechanisms of auditory neuropathy exist | |
Pappa et al. | Hair cell and neural contributions to the cochlear summating potential | |
Santarelli et al. | OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation | |
Shepherd et al. | Long‐term sensorineural hearing loss induces functional changes in the rat auditory nerve | |
Santarelli et al. | Neural and receptor cochlear potentials obtained by transtympanic electrocochleography in auditory neuropathy | |
Shepherd et al. | Response of inferior colliculus neurons to electrical stimulation of the auditory nerve in neonatally deafened cats | |
Singh et al. | Vestibular evoked myogenic potentials in children with sensorineural hearing loss | |
Parkes et al. | Vestibular evoked myogenic potential testing as an objective measure of vestibular stimulation with cochlear implants | |
Huang et al. | Mutation of OPA1 gene causes deafness by affecting function of auditory nerve terminals | |
Santarelli et al. | Abnormal cochlear potentials from deaf patients with mutations in the otoferlin gene | |
Meli et al. | Vestibular function after cochlear implant surgery | |
Cushing et al. | Incidence and characteristics of facial nerve stimulation in children with cochlear implants | |
Braun et al. | Triphasic pulses in cochlear implant patients with facial nerve stimulation | |
He et al. | Temporal response properties of the auditory nerve in implanted children with auditory neuropathy spectrum disorder and implanted children with sensorineural hearing loss | |
Lee et al. | Effect of M-current modulation on mammalian vestibular responses to transient head motion | |
Gordon et al. | Binaural processing in children using bilateral cochlear implants | |
Zhang et al. | Neural adaptation and behavioral measures of temporal processing and speech perception in cochlear implant recipients | |
O'Driscoll et al. | Brain stem responses evoked by stimulation with an auditory brain stem implant in children with cochlear nerve aplasia or hypoplasia | |
Bath et al. | The vestibulo‐collic reflex | |
Herrmann et al. | Auditory brainstem implant: electrophysiologic responses and subject perception | |
de Sauvage et al. | Electrical and physiological changes during short-term and chronic electrical stimulation of the normal cochlea | |
Heffer et al. | Examining the auditory nerve fiber response to high rate cochlear implant stimulation: chronic sensorineural hearing loss and facilitation |